We constructed miBrains from isogenic sets of APOE3/3 and APOE4/4 iPSCs (32) and evaluated GFAP signal, given the increasing utilization of GFAP as a biomarker for AD (73, 74). This evidence concerns the gene GFAP and Alzheimer disease.